CRISPR Therapeutics AG CRSP
NASDAQ CRSP
$45.38 +0.23 (+0.52%)
As of: Nov 11, 2026 · 10:55 AM EST

CRISPR Therapeutics AG (CRSP) Long-Term Debt Issuances (2016 - 2026)

Updated

CRISPR Therapeutics AG's Long-Term Debt Issuances came in at $600 million for Q1 2026.

Analysis

CRISPR Therapeutics AG (CRSP) Long-Term Debt Issuances (2016 - 2026) Analysis & Trends

For FY2016, CRISPR Therapeutics AG's Long-Term Debt Issuances was $35.01 million, down 8.4% from FY2015.

  • Going back by year, Long-Term Debt Issuances was $38.24 million in FY2015.
  • The Q1 2026 figure represents the lowest quarterly Long-Term Debt Issuances since Q4 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 9.98 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 CRISPR Therapeutics AG 4.37 Bn -4.68 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 600.00 Mn
Dec 31, 2016 10,000.00
Mar 31, 2016 35.00 Mn
API Access

CRISPR Therapeutics AG Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=CRSP&period=max&api_key=YOUR_API_KEY